Leptin-specific mechanisms for impaired liver regeneration in ob/ob mice after toxic injury

Gastroenterology

Volumn 124, Issue 5, 2003, Pages 1451-1464

  Leclercq, Isabelle A ^a   Field, Jacqueline ^a   Farrell, Geoffrey C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; CYCLIN D1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LEPTIN; STAT3 PROTEIN; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; CYTOKINE RELEASE; HOMOZYGOSITY; LIVER CELL; LIVER REGENERATION; LIVER TOXICITY; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0037621952     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(03)00270-1     Document Type: Article

References (57)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-1231.
2. Underwoodground KE. Prevalence of fatty liver in healthy male adults accidentally killed. Aviat Space Environ Med 1984;55:59-61.
3. Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steato-hepatitis. Semin Liver Dis 2001;21:27-41.
4. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002;122:1649-1657.
5. Behrns KE, Tsiotos GG, De Souza NF, Krishna MK, Ludwig J, Nagorney DM. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 1998;2:292-298.
6. D'Alessandro A, Kalayoglu M, Sollinger H, Hoffmann RM, Reed A, Knechtle SJ, Pirsch JD, Hafez GR, Lorentzen D, Belzer FO. The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation 1991;51:157-163.
7. Todo S, Demetris A, Teperman L, Podesta L, Shaver T, Tzakis A, Starzl TE. Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 1989;47:903-905.
8. Selzner M, Clavien PA. Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway. Hepatology 2000;31:35-42.
9. Yang SQ, Lin HZ, Mandal AK, Huang J, Diehl AM. Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. Hepatology 2001;34:694-706.
10. Picard C, Lambotte L, Starkel P, Sempoux C, Saliez A, Van Den Berge V, Horsmans Y. Steatosis is not sufficient to cause an impaired regenerative response after partial hepatectomy in rats. J Hepatol 2002;32:645-652.
11. Friedman JM. Leptin, leptin receptor, and the control of body weight. Nutr Rev 1997;56:S38-S46.
12. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998;394:897-901.
13. Wolf G, Chen S, Han DC, Ziyadeh FN. Leptin and renal disease. Am J Kidney Dis 2002;39:1-11.
14. Leclercq IA, Farrell GC, Schriemer R, Robertson GR. Leptin is essential for hepatic fibrogenic response to chronic liver injury. J Hepatol 2002;37:206-213.
15. Ikejima K, Honda H, Yoshikawa M, Hirose M, Kitamura T, Takei Y, Sato N. Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals. Hepatology 2001;34:288-297.
16. Ikejima K, Takei Y, Honda H, Hirose M, Yoshikawa M, Zhang YJ, Lang T, Fukuda T, Yamashina S, Kitamura T, Sato N. Leptin-receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterology 2002;122:1399-1410.
17. Saxena NK, Ikeda K, Rockey DC, Friedman SL, Anania F. Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology 2002;35:761-771.
18. Honda H, Ikejima K, Hirose M, Yoshikawa M, Lang T, Enomoto N, Kitamura T, Takei Y, Sato N. Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver. Hepatology 2002;36:12-21.
19. Russel WE, Coffrey RJJ, Ouellette AJ, Moses HL. Type β transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci U S A 1988;85:5126-5130.
20. Fausto N. Multifunctional roles for TGFβ. Lab Invest 1991;65:497-499.
21. Stallmeyer B, Kampfer H, Podda M, Kaufmann R, Pfeilschifter J, Frank S. A novel keratinocyte mitogen: regulation of leptin and its functional receptor in skin repair. J Invest Dermatol 2001;117:98-105.
22. Hardwick JC, Van Den Brink GR, Offerhaus GJ, Van Deventer SJ, Peppelenbosch MP. Leptin is a growth factor for colonic epithelial cells. Gastroenterology 2001;121:79-90.
23. Tsuchiya T, Shimizu H, Horie T, Mori M. Expression of leptin receptor in lung: leptin as a growth factor. Eur J Pharmacol 1999;365:273-279.
24. Wolf G, Hamann A, Han DC, Thaiss F, Ziyadeh FN, Stahk RA. Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Int 1999;56:860-872.
25. Frank S, Stallmeyer B, Kampfer H, Kolb N, Pfeilschifter J. Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair. J Clin Invest 2000;106:501-509.
26. Rao MS, Papreddy K, Abecassis M, Hashimoto T. Regeneration of liver with marked fatty change following partial hepatectomy in rats. Dig Dis Sci 2001;46:1821-1826.
27. Rao MS, Reddy JK. The effect of microvesicular fatty changes on liver regeneration after partial hepatectomy. Hepatogastroenterology 2000;47:912-915.
28. Zhang BH, Weltman M, Farrell GC. Does steatohepatitis impair liver regeneration? A study in a dietary model of non-alcoholic steatohepatitis. J Gastroenterol Hepatol 1999;14:133-137.
29. Farrell G, Robertson G, Leclercq I, Horsmans Y. Liver regeneration in obese mice with fatty livers; does the impairment have relevance for other types of fatty liver disease (letter)? Hepatology 2002;35:731-732.
30. Leclercq I, Field J, Enriquez A, Farrell GC, Robertson GR. Constitutive and inducible expression of hepatic CYP2E1 in leptin deficient ob/ob mice. Biochem Biophys Res Commun 2000;268:337-344.
31. Teoh N, dela Pena A, Farrell GC. Hepatic ischemic preconditioning in mice is associated with activation of NF-κB, p38 kinase and cell cycle entry. Hepatology 2002;36:94-102.
32. Essani NA, McGuire GM, Manning Am, Jaeschke H. Endotoxin-induced activation of nuclear factor transcription factor-κB and expression of E-selectin messenger RNA in hepatocytes, Kupffer cells and endothelial cells in vivo. J Immunol 1996;156:2956-2963.
33. Starkel P, Horsmans Y, Sempoux C, De Saeger C, Wary J, Lause P, Maiter D, Lambotte L. After portal branch ligation in rat, nuclear factor B, interleukin-6, signal transducers and activators of transcription 3, c-fos, c-myc, and c-jun are similarly induced in the ligated and nonligated lobes. Hepatology 1999;29:1463-1470.
34. Doree M, Galas S. The cyclin-dependent protein kinases and the control of cell division. FASEB J 1994;8:1114-1121,
35. Fausto N. Liver regeneration. In: Arias IM, ed. The liver: biology and pathobiology (4th ed). Philadelphia: Lippincott Williams & Wilkins, 2001:591-610.
36. Loyer P, Cariou S, Glaise D, Bilodeau M, Baffet G, Guguen-Guillouzo C. Growth factor dependence of progression through G1 and S phases of adult rat hepatocytes in vitro. Evidence of a mitogen restriction point in mid-late G1. J Biol Chem 1996;271:11484-11492.
37. Albrecht JH, Hansen LK, Cyclin D1 promotes mitogen-independent cell cycle progression in hepatocytes. Cell Growth Differ 1999;10:397-404.
38. Schmiedeberg P, Biempica L, Czaja MJ. Timing of protooncogene expression varies in toxin-induced liver regeneration. J Cell Physiol 1993;154:294-300.
39. Yamada Y, Fausto N. Deficient liver regeneration after carbon tetrachloride injury in mice lacking type I but not type 2 tumor necrosis factor receptor. Am J Pathol 1998;152:1577-1589.
40. Karin M, Cao Y, Greten FR, Li ZW. NF-κB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002;2:301-310.
41. Bruccoieri A, Gallucci R, Germolec DR, Blackshear P, Simeonova P, Thurman RG, Luster MI. Induction of early-immediate genes by tumor necrosis factor alpha contribute to liver repair following chemical-induced hepatotoxicity. Hepatology 1997;25:133-141.
42. Czaja MJ, Xu J, Alt E. Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor. Gastroenterology 1995;108:1849-1854.
43. Teoh N, Leclercq I, dela Pena A, Farrell GC. Low-dose TNFα protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning. Hepatology 2003;37:118-128.
44. Ledda-Columbano GM, Pibiri M, Loi R, Perra A, Shinozuka H, Columbano A. Early increase in cyclin D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1,4-bis benzene [2-(3,5-dichloropyridyloxyl)]. Am J Pathol 2000;156:9197.
45. Torbenson M, Yang SQ, Liu HZ, Huang J, Gage W, Diehl AM. STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers. Am J Pathol 2002;161:155-161.
46. Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A 1997;94:2557-2562.
47. Campbell JS, Prichard L, Shaper F, Schmitz J, Stephenson-Famy A, Rosenfeld ME, Agast GM, Heinrich PC, Fausto N. Expression of suppressors of cytokine signaling during liver regeneration. J Clin Invest 2001;107:1285-1292.
48. Tartaglia LA, The leptin receptor. J Biol Chem 1997;272:6093-6096.
49. Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci U S A 1997;94:1441-1446.
50. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, Taub R. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996;274:1379-1383.
51. Streetz KL, Luedde T, Manns MP, Trautwein C. Interleukin 6 and liver regeneration. Gut 2000;47:309-312.
52. INK4D by IL-10 contributes to inhibition of macrophage proliferation. J Immunol 2000;164:4607-4615.
53. Wustefeld T, Rakemann T, Kubicka S, Manns MP, Trautwein C. Hyperstimulation with interleukin 6 inhibits cell cycle progression after hepatectomy in mice. Hepatology 2000;32:514-522.
54. Lee FY, Li Y, Yang EK, Yang SQ, Lin HZ, Trush MA, Dannenberg J, Diehl AM. Phenotypic abnormalities in macrophages from leptin-deficient, obese mice. Am J Physiol 1999;276:C286-C294.
55. Fagioni R, Fantuzzi G, Gabay C, Moser A, Dinarello CA, Feingold KR, Grunfeld C. Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol 1999;276:R136-R142.
56. Faggioni R, Jones-Carson J, Reed DA, Dinarello CA, Feingold KR, Grunfeld C, Fantuzzi G. Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor α and IL-18. Proc Natl Acad Sci U S A 2000;97:2367-2372.
57. Li Z, Lin H, Yang S, Diehl AM. Murine leptin deficiency alters Kupffer cell production of cytokines that regulate the innate immune system. Gastroenterology 2002;123:1304-1310.